International Network of VENous Thromboembolism Clinical Research Networks


StAtins for Venous Event Reduction in Patients With Venous Thromboembolism: A Pilot Study Assessing Feasibility of an RCT to Evaluate if Generic Rosuvastatin Reduces the Risk of Recurrent VTE in Patients With Symptomatic Major VTE


( NCT02679664


OHRI (Ottawa Hospital Research Institute)


  • Pilot trial recruited in Canada and Norway
  • Recruitment Completed
  • Secured Funding to Begin Full Trial


Randomized open-label pilot study to determine the feasibility of recruitment to a trial of rosuvastatin vs. no rosuvastatin for secondary prevention of VTE and determine if rosuvastatin can reduce post-thrombotic syndrome

Participating Sites

CanVECTOR logo

Lead Network:

Flag of Canada


Canada, Norway,

Lead Investigators

Dr. Marc Rodger

Dr. Marc Rodger, MD, MSc

Dr. Waleed Ghanima, MD, PhD


* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.